# OPM Biosciences

custom OPM-CHO / OPM-293 media and feeds doubling antibody titre via high-throughput screening.

Source: https://en.bioecon.ru/companies/opm-biosciences/
Updated: 2026-07-06

- Country: China

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | CNY 354.91 million (FY 2025) | https://financialfilings.com/companies/shanghai-opm-biosciences-co-ltd/, https://sg.finance.yahoo.com/quote/688293.SS/key-statistics/ |
| Production site | Two cell culture media manufacturing sites in China | https://opmbio.com/en/manufacturing-capacity |
| Capacity | Liquid media capacity up to 2000 L/batch; dry powder up to 2000 kg/batch (Facility #2) | https://opmbio.com/en/custom-services, https://opmbio.com/en/manufacturing-capacity |
| Certification | ISO 9001:2015 certified; GMP compliant | https://opmbio.com/, https://opmbio.com/en/custom-services |
| Regulatory approval | CSRC registration approval for asset restructuring (Dec 2025) and re-certified as High and New Technology Enterprise (Jan 2026) | https://law.asia/press-release/fangda-opm-biosciences-in-obtaining-csrc-registration-approval-for-a-landmark-dual-first-of-its-kind-restructuring-transaction/ |

Independent sources: financialfilings.com, law.asia, sg.finance.yahoo.com

## Technologies

- [Media manufacturing (B2B production equipment)](https://en.bioecon.ru/technology/media-manufacturing-equipment/)